Vascular Medicine Journal Enters 25th Year of Publication (PDF)
Posted January 16, 2020
Vascular Medicine journal (Impact Factor: 2.786) enters its 25th year of publication with a series of changes to rejuvenate its leadership team including expansion of the Vascular Medicine Editorial Board to include 11 new members (88 total) and provide expanded multispecialty perspective and more diversified experience in vascular medicine research.
McLean, VA: The Society for Vascular Medicine held its 30th Annual Scientific Sessions in McLean, VA earlier this month and announced its new leadership as well as presented its annual awards.
Dr. Raghu Kolluri of OhioHealth Heart & Vascular was elected president for the 2019-2021 term. He succeeds Dr. Heather Gornik of University Hospitals Harrington Heart & Vascular Institute. Dr. Herbert D. Aronow of Lifespan Cardiovascular Institute takes over as president-elect. Dr. Elizabeth V. Ratchford of Johns Hopkins is the new secretary and Dr. Ido Weinberg of Massachusetts General Hospital was elected treasurer.
From Vascular Medicine: First International Consensus on Fibromuscular Dysplasia (PDF)
Posted January 16, 2019
The “First international consensus on the diagnosis and management of fibromuscular dysplasia” (FMD) has been published online first today in Vascular Medicine and the Journal of Hypertension. The consensus document was written by a committee of international experts in the field commissioned by the Society for Vascular Medicine (SVM) and the Working Group “Hypertension and the Kidney” of the European Society of Hypertension (ESH). The writing committee was co-chaired by Dr. Heather Gornik (Cleveland, OH, USA) of SVM and Dr. Alexandre Persu (Brussels, Belgium) of ESH and includes leading clinical experts and researchers in the field of FMD.
From Vascular Medicine: Focus on Vascular Imaging and Diagnostics (PDF)
Posted April 10, 2018
For 1 month only, the April 2018 issue of Vascular Medicine, published by SAGE Publishing, is available for free download. This collection of manuscripts will update the reader on the latest imaging and diagnostic techniques for vascular disease. The issue includes six original research articles covering a wide range of imaging and diagnostic techniques for patients with PAD, diabetes, and pulmonary embolism, including ABI testing, duplex ultrasound, MRA, and CTA. Vascular medicine thought leaders, Dr. Joshua Beckman (Vanderbilt University) and Dr. Victor Aboyans (Dupuytren University Hospital), provide editorial commentary.
From Vascular Medicine: Erectile dysfunction is red flag for silent early cardiovascular disease
Posted December 15, 2017
In the article entitled “The relationship of erectile dysfunction and subclinical cardiovascular disease: A systematic review and meta-analysis,” Drs. Chukwuemeka Osondu (Baptist Health South Florida), Bryan Vo (Florida International University), Ehimen Aneni (Mount Sinai Medical Center), and colleagues sought to establish erectile dysfunction as a simple and effective marker of underlying subclinical CV disease. They hypothesized that “measures of erectile dysfunction could be a simple effective CV disease risk stratification tool, particularly in young men who are less likely to undergo aggressive CVD risk assessment and management.”
Vascular Medicine Issues Special Call for Papers
Posted August 4, 2017
Vascular Medicine is currently soliciting original research and review articles for a Special Issue devoted to Vascular Imaging and Diagnostics. The issue is planned for publication in Spring of 2018.
SVM's DVT Website Takes Bronze
Posted July 11, 2017
The Deep Vein Thrombosis (DVT) Toolkit, SVM’s web-based resource for medical practices and patients, has been recognized with a Bronze Award in the Web-Based Digital Health category from the 2017 Spring Digital Health AwardsSM.
Dr. Tabit’s received first prize honors for his presentation, Increased Tumor Necrosis Factor-D Levels in Patients with Continuous-Flow Left Ventricular Assist Devices Mediate Vascular Instability and Are Associated with Higher Non-Surgical Bleeding.
SVM Bestows Master of SVM Honors on James Froehlich and Emile R. Mohler
Posted June 20, 2017
The Society for Vascular Medicine bestowed the Master of SVM (MSVM) designation during the 2017 SVM Annual Meeting on James B. Froehlich, MD, MPH, University of Michigan and Past President of SVM, and Emile R. Mohler, MD, Hospital of the University of Pennsylvania. The MSVM designation is given in recognition of extraordinary service, selfless dedication and enlightened leadership to the SVM and the field of vascular Medicine.
SVM Honors Bruce Gray with 2017 Jess R. Young Outstanding Educator Award
Posted June 20, 2017
This award is presented in honor of Jess R. Young, in recognition of his ground-breaking work in the field of vascular medicine, his pre-eminence as an educator and his vision for multi-specialty programs.
Heather Gornik Elected President of the Society for Vascular Medicine
Posted June 18, 2017
Heather L. Gornik, MD, was elected President of the Society for Vascular Medicine (SVM) during the 2017 SVM Annual Meeting. Dr. Gornik is the 15th president of SVM since its founding in 1989, and the first woman to serve in this role.
Focused Issue on Vascular Disease in Women Available Now in Vascular Medicine
Posted April 21, 2017
Vascular disease is a leading cause of morbidity and death worldwide. There are important sex-related differences in risk factors, clinical manifestations, and therapeutic outcomes in peripheral vascular diseases, including peripheral artery disease (PAD), venous thromboembolism (VTE), and aortic disease. In addition, some vascular conditions predominantly affect women. With this in mind, Vascular Medicine, the official journal of the Society for Vascular Medicine, dedicated its April 2017 issue to the topic of Vascular Disease in Women.
The Society for Vascular Medicine (SVM) is pleased to announce that two invited keynote speakers will address its 28th Annual Scientific Sessions, June 14-17, 2017, in New Orleans. Both addresses will be given on Thursday, June 15. Mark A. Creager, MD, FAHA, FACC, MSVM, will give the 2017 Founders' Lecture. C. Noel Bairey Merz, MD, FACC, FAHA, will present a keynote address on Sex-related Differences in Cardiovascular Disease to open a session called Vascular Disease in Women.
SVS Patient Safety Organization Announces New Vascular Medicine Registry
Posted Nov. 29, 2016
A new Vascular Medicine Registry will be launched in early 2017 by the Society for Vascular Surgery (SVS) and the Society for Vascular Medicine (SVM). The registry will be housed within the SVS Patient Safety Organization (SVS PSO), which was established to collect and analyze data to improve the quality of vascular care, and to do so in a neutral, de-identified environment. This will be the first data registry to study outcomes of medical management as compared to interventional and surgical treatments.
Aortic disease, including aortic aneurysm and aortic dissection, is an important cause of cardiovascular morbidity and death. There have been exciting developments in caring for patients with aortic aneurysm and dissection, including great advances in diagnosis and endovascular therapies. Despite this, there remains significant gaps in knowledge of the understanding of mechanisms of aortic pathology and opportunity to further improve patient care. With this in mind, Vascular Medicine, the official journal of the Society for Vascular Medicine, has dedicated its June 2016 issue to this important topic.
The Society for Vascular Medicine (SVM) is a part of a coalition of five leading nonprofit professional societies that has made recommendations for the treatment of peripheral artery disease (PAD) to the Centers for Medicare and Medicaid Services (CMS) Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) panel. The coalition’s recommendations are explained in an editorial that will appear in Vascular Medicine, the official journal of SVM. The editorial was made available on April 10 on the Vascular Medicine website.
The MEDCAC panel was convened to examine scientific evidence for lower-extremity PAD treatments that aim to improve health outcomes in Medicare beneficiaries and to address areas where evidence gaps exit related to lower-extremity PAD. The panel discussed care for patients with three levels of peripheral artery disease: asymptomatic, intermittent claudication, and critical limb ischemia.